chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site bruising, Injection site discharge, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Error: Leaking from Injection Site-
Age: 14.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Loss of consciousness, Respiratory arrest, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Severe, Systemic: Passed out-loss of consciousness-epi given paramedics called-Severe, Systemic: Weakness-Severe, Additional Details: Patient loss consciousness-stopped breathing for approx 15 secs-epi given-instant rebound-paramedics came took to ambulance for observation-released to wife-followed up with wife, patient is ok-sleeping now
Age: 17.0
Sex: F
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient received 3 vaccines, after vaccines were complete she said she didnt feel well and laid on table. BP 100/68 pulse 86 and oxygen was 100 at the time. Patient aroused and provided water
Age: 1.75
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Erythema multiforme, Rash
Clinical narrative: Erythema multiforme minor- rash on the face, thighs, abdomen and arms.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Additional Details: Ice pack administered to child. Advised mother to give motrin as needed for pain. Counseled mom to continue to monitor and seek higher level of care if worsening.
Age: 90.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Injection site pruritus, Musculoskeletal stiffness
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Systemic: Stiff Neck-Medium
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal discomfort, Biopsy skin abnormal, Blood test, Chills, Cutaneous vasculitis
Clinical narrative: 8/12/2021- about 4 hours after vaccine started with headache, chills, body started hurting, then I went to bed and all through the night I was sick to my stomach and got a vest bad sore throat. Ankles started to have swollen into them.  9/10/2021- Started throwing up a few hours after with pains in my stomach and swelling of my legs again and now my hands as well. Red dots start on my legs and would come and go blow my knees.  2/11/2022- After the booster I ended up with swelling of my hands and feet. Little red dots on my legs would come and go way more than I got on my legs after 2nd shot Started with a lot of cramping in my toes and very bad headaches worse then i have ever had in my life
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Joint swelling, Muscle spasms, Oropharyngeal pain, Pain
Clinical narrative: 8/12/2021- about 4 hours after vaccine started with headache, chills, body started hurting, then I went to bed and all through the night I was sick to my stomach and got a vest bad sore throat. Ankles started to have swollen into them.  9/10/2021- Started throwing up a few hours after with pains in my stomach and swelling of my legs again and now my hands as well. Red dots start on my legs and would come and go blow my knees.  2/11/2022- After the booster I ended up with swelling of my hands and feet. Little red dots on my legs would come and go way more than I got on my legs after 2nd shot Started with a lot of cramping in my toes and very bad headaches worse then i have ever had in my life
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Peripheral swelling, Rash, Rash erythematous, Vomiting
Clinical narrative: 8/12/2021- about 4 hours after vaccine started with headache, chills, body started hurting, then I went to bed and all through the night I was sick to my stomach and got a vest bad sore throat. Ankles started to have swollen into them.  9/10/2021- Started throwing up a few hours after with pains in my stomach and swelling of my legs again and now my hands as well. Red dots start on my legs and would come and go blow my knees.  2/11/2022- After the booster I ended up with swelling of my hands and feet. Little red dots on my legs would come and go way more than I got on my legs after 2nd shot Started with a lot of cramping in my toes and very bad headaches worse then i have ever had in my life
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 38.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient was due for a COVID Booster. Received a Primary in error.
Age: 40.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Pins and needles sensation and numb feeling in bilateral hands and feet starting 2 hours after administration and has continued for 24+.  Awaiting employer instructions for treatment.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Injection site pain, Nausea, Vomiting
Clinical narrative: NauseaVomiting chills, fatigue, pain injection site Narrative:
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hiccups
Clinical narrative: Hiccups lasting about 36 hours.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient came in for a COVID Booster. Received Primary in error.
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 13.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Incorrect product formulation administered
Clinical narrative: Monovalent, Moderna COVID-19 vaccine administered to patient as a booster dose. Patient was due for bivalent, Moderna COVID-19 vaccine booster dose.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient came in for a COVID Booster. Received a Primary in error.
Age: 0.33
Sex: F
Vaccine: DTAPIPV, HIBV, PNC13, RV5
Symptoms: Unevaluable event
Clinical narrative: Monitor
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: No adverse event related to the vaccination. I have been experiencing symptoms that may be due to lung cancer. I am scheduled for a pulmonary CT scan to determine the cause.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19
Clinical narrative: Hospitalization for acute respiratory failure due to COVID-19 on dates 8/24/22-8/30/22.  Treated with dexamethasone, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient came in for a COVID Bivalent Booster. Was given Primary in error.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea
Clinical narrative: Hospitalization for shortness of breath due to COVID-19 on dates 8/22/2022-9/1/2022..  Treated with dexamethasone, baricitinib, Remdesivir, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient came in for a COVID Bivalent Booster. Received a Primary in error.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Back pain, CSF protein increased, Computerised tomogram spine, Immunoglobulin therapy, Lumbar puncture abnormal
Clinical narrative: Patient presented to the emergency department on 10/26/2022 for evaluation of gradually worsening of weakness in both legs and back pain that started on 10/21/2022.   She started feeling this way after getting her Covid booster earlier that day.  She also received an influenza vaccine a few days AFTER symptoms started (influenza vaccine was administered on 10/24/2022).   A CT thoracic and lumbar spine with contrast showed no central canal stenosis.  Neurology was consulted. LP was done which revealed albumino-cytological dissociation. Given concern for post-vaccine mediated Guillain Barre Syndrome, patient was started on IVIG. Completed 5 days of IVIG with mild improvement. Transferred to acute inpatient rehab unit to continue rehabilitation.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Muscular weakness, Scan with contrast normal
Clinical narrative: Patient presented to the emergency department on 10/26/2022 for evaluation of gradually worsening of weakness in both legs and back pain that started on 10/21/2022.   She started feeling this way after getting her Covid booster earlier that day.  She also received an influenza vaccine a few days AFTER symptoms started (influenza vaccine was administered on 10/24/2022).   A CT thoracic and lumbar spine with contrast showed no central canal stenosis.  Neurology was consulted. LP was done which revealed albumino-cytological dissociation. Given concern for post-vaccine mediated Guillain Barre Syndrome, patient was started on IVIG. Completed 5 days of IVIG with mild improvement. Transferred to acute inpatient rehab unit to continue rehabilitation.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Cholecystectomy, Hepatobiliary scan, Hepatobiliary scan abnormal
Clinical narrative: Patient had positive COVID test on 10/15/22 prior to admission.  Still on COVID precautions during admission due to her being considered severely immunocompromised.  Provider d/c note:  "Patient presented to the ED for abdominal pain s/p RYGB on 9/13/22. On Admissions a HIDA was done that showed sgi decrease EF. She was scheduled for a RALC on Monday 10/24/22. The procedure went well and patient was alert and oriented in her room. She was in pain and Dilaudid x 1 received. She was in pain and plans were made for her to try and ambulate. The next day on 10/26 she was having some nausea and vomiting but was able to ambulate. Overall she improved and when seen at bedside on 10/28 was not nauseous and was deemed stable for discharge."
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Immunodeficiency, Laparoscopic surgery, Nausea, Pain, Robotic surgery
Clinical narrative: Patient had positive COVID test on 10/15/22 prior to admission.  Still on COVID precautions during admission due to her being considered severely immunocompromised.  Provider d/c note:  "Patient presented to the ED for abdominal pain s/p RYGB on 9/13/22. On Admissions a HIDA was done that showed sgi decrease EF. She was scheduled for a RALC on Monday 10/24/22. The procedure went well and patient was alert and oriented in her room. She was in pain and Dilaudid x 1 received. She was in pain and plans were made for her to try and ambulate. The next day on 10/26 she was having some nausea and vomiting but was able to ambulate. Overall she improved and when seen at bedside on 10/28 was not nauseous and was deemed stable for discharge."
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Patient had positive COVID test on 10/15/22 prior to admission.  Still on COVID precautions during admission due to her being considered severely immunocompromised.  Provider d/c note:  "Patient presented to the ED for abdominal pain s/p RYGB on 9/13/22. On Admissions a HIDA was done that showed sgi decrease EF. She was scheduled for a RALC on Monday 10/24/22. The procedure went well and patient was alert and oriented in her room. She was in pain and Dilaudid x 1 received. She was in pain and plans were made for her to try and ambulate. The next day on 10/26 she was having some nausea and vomiting but was able to ambulate. Overall she improved and when seen at bedside on 10/28 was not nauseous and was deemed stable for discharge."
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient came in for a COVID Bivalent booster. Received a Primary in error.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Transient ischaemic attack
Clinical narrative: Hospitalization for TIA, and tested positive for COVID-19 on dates 8/25/2022-8/27/2022.  Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient came in for a COVID Bivalent booster. Received a Primary in error.
Age: 16.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID-19
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus disorder
Clinical narrative: SINUS ISSUES
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: The patient who is 10 years old was given the adults dose if Pfizer covid bivalent booster. The patient accompanying with the parent walked out the pharmacy without reporting any side effects at the moment
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Syncope
Clinical narrative: Hospitalization for syncope (tested COVID-19 positive as an outpatient) on dates 8/25/22-8/29/22. Treated with no COVID medications.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient came in for a COVID Bivalent booster. Received a Primary in error.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: Patient came in for a COVID Bivalent booster. Received a Primary in error.
Age: 26.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Suppressed lactation
Clinical narrative: Breast milk supply dropped significantly. Normal output prior to vaccine 35-40oz a day, after first dose 20-25oz a day, then 10-15oz a day after second dose.
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Diarrhoea, Disorientation, Pyrexia, Tinnitus
Clinical narrative: Diarrhea, body chills, fever, ears ringing, shaking, disoriented,
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tremor
Clinical narrative: Diarrhea, body chills, fever, ears ringing, shaking, disoriented,
Age: 64.0
Sex: M
Vaccine: FLUR4, VARZOS
Symptoms: Diarrhoea, Fatigue, Nausea, Pain in extremity
Clinical narrative: He got his vaccines, initially he had no reaction  Slight soreness in both arms, but he played golf 2 days later and he played golf again 3 days later.  On Monday 10/31/22 he had loose stools, which he thought it was something he ate the day before and felt that it would go away.  This is now day #3 and he is still having the same symptoms, and feels that it is related to his vaccines.  He may have a low grade fever.  The first day he did have some fatigue and a little nausea, but that went away within the next day.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Hospitalization for chest pain on dates 8/27/2022-9/2/2022. Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Device connection issue
Clinical narrative: Faulty syringe; the top of the syringe popped off as i went to adminsister the vaccine. I had to readminister.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Ageusia, Diplopia, Pain, Sensory loss
Clinical narrative: Lack of strength, double vision, body ache,  for 6 days  Loss of taste on going
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Mental status changes
Clinical narrative: Hospitalization for weakness and altered mental status due to COVID-19 on dates  8/29/2022-9/2/2022.  Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: Hospitalization for COVID-19 Pneumonia on dates 8/30/22-9/2/22.  Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 5.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site inflammation, Injection site swelling, Injection site warmth
Clinical narrative: REACTION TO FLU SHOT RECIEVED ON TUESDAY 10/25. LEFT UPPER ARM SWOLLEN INFLAMED AND HOT TO THE TOUCH.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Biopsy skin, Blood test abnormal, Chest pain, Red blood cell count increased
Clinical narrative: I experienced an elevated red blood count cell, Alopecia and chest pain.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep study
Clinical narrative: I experienced an elevated red blood count cell, Alopecia and chest pain.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pulmonary embolism
Clinical narrative: Hospitalization for Acute Pulmonary embolism (recent COVID diagnosis outpatient) on dates 9/1/22-9/3/22.  Treated with vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Arteriogram carotid abnormal, Asthenia, Basal ganglia infarction, Basilar artery stenosis
Clinical narrative: Provider d/c note:  "70 YO male with h/o HTN, T2DM, Depression who presented to ED with chief complaint of weakness. The patient reports generalized weakness worse in the left-leg since waking up this morning. He reports that he had difficulty walking which prompted a call to EMS for further evaluation. Of note, patient was evaluated in September 2022 for Bell's Palsy and completed a one week course of Valtrex. He denies chest pain, chest pressure, dyspnea, cough, wheezing, HA, lightheadedness. He reports intermittent paresthesia worse at the b/l feet which is unchanged from baseline. He reports no bowel or bladder incontinence.   In the ED, patient's vitals are significant for BP of 152/76, HR 102, Temp 100.7F, Resp 20, SpO2 89% on RA. He is not on supplemental oxygen at baseline. Initial work-up remarkable for WBC 13.4, Na 133, initial lactate 3.7, normal 4-hour lactate, Procal of 0.32, D-dimer of 610, CRP of 3.8. Coags normal. Initial troponin 23, repeat 22. RVP positive for COVID. Head CT significant for no acute infarct, thrombosis or hemorrhage. Chronic right striatocapsular and R cerebellar small vessel infarcts. CTA head and neck with moderately severe mid-basilar artery and distal left P2 segment stenosis, no hemodynamically significant cervical arterial occlusive change. Chest XR remarkable for subtle nonspecific bibasilar patchy opacities.    Patient was admitted for further stroke work-up and treatment for COVID pneumonia/pneumonitis.   Hospital Course:  Patient's respiratory status improved after hospital Day 1 on oral decadron and IV remdesivir. Patient completed a 5-day course of IV Remdesivir and 5-day course of oral Decadron with plans for additional Decadron therapy for 5-days after discharge. The patient's left-sided weakness resolved. Further stroke work-up with MRI was unremarkable. Echo was remarkable for preseverbed EF with mild grade 1 diastolic dysfunction and mild left atrial enlargement with mild valvular disease but no evidence of active clot or thrombus. With his lipid panel and A1c of 9%, optimization of risk factors was started with starting Lipitor 80mg nightly, Lisinopril 5mg daily, and ASA 81mg daily. The patient's blood sugars were controlled with SSI and Lantus 15U nightly. He was discharged on Soliqua 15U daily and recommendations to stop Metformin as patient was admitted with evidence of lactic acidosis. The patient was recommended to decrease his nightly Remeron from 45mg to 15mg. He was also scheduled for an outpatient sleep medicine referral due to known history of OSA and noncompliance with CPAP, as this likely has contributed to his current condition. The patient was discharged in stable condition with recommendations to have close PCP follow up and outpatient sleep study as mentioned above."
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bell's palsy, Blood lactic acid, Blood sodium decreased, Body temperature increased, C-reactive protein increased
Clinical narrative: Provider d/c note:  "70 YO male with h/o HTN, T2DM, Depression who presented to ED with chief complaint of weakness. The patient reports generalized weakness worse in the left-leg since waking up this morning. He reports that he had difficulty walking which prompted a call to EMS for further evaluation. Of note, patient was evaluated in September 2022 for Bell's Palsy and completed a one week course of Valtrex. He denies chest pain, chest pressure, dyspnea, cough, wheezing, HA, lightheadedness. He reports intermittent paresthesia worse at the b/l feet which is unchanged from baseline. He reports no bowel or bladder incontinence.   In the ED, patient's vitals are significant for BP of 152/76, HR 102, Temp 100.7F, Resp 20, SpO2 89% on RA. He is not on supplemental oxygen at baseline. Initial work-up remarkable for WBC 13.4, Na 133, initial lactate 3.7, normal 4-hour lactate, Procal of 0.32, D-dimer of 610, CRP of 3.8. Coags normal. Initial troponin 23, repeat 22. RVP positive for COVID. Head CT significant for no acute infarct, thrombosis or hemorrhage. Chronic right striatocapsular and R cerebellar small vessel infarcts. CTA head and neck with moderately severe mid-basilar artery and distal left P2 segment stenosis, no hemodynamically significant cervical arterial occlusive change. Chest XR remarkable for subtle nonspecific bibasilar patchy opacities.    Patient was admitted for further stroke work-up and treatment for COVID pneumonia/pneumonitis.   Hospital Course:  Patient's respiratory status improved after hospital Day 1 on oral decadron and IV remdesivir. Patient completed a 5-day course of IV Remdesivir and 5-day course of oral Decadron with plans for additional Decadron therapy for 5-days after discharge. The patient's left-sided weakness resolved. Further stroke work-up with MRI was unremarkable. Echo was remarkable for preseverbed EF with mild grade 1 diastolic dysfunction and mild left atrial enlargement with mild valvular disease but no evidence of active clot or thrombus. With his lipid panel and A1c of 9%, optimization of risk factors was started with starting Lipitor 80mg nightly, Lisinopril 5mg daily, and ASA 81mg daily. The patient's blood sugars were controlled with SSI and Lantus 15U nightly. He was discharged on Soliqua 15U daily and recommendations to stop Metformin as patient was admitted with evidence of lactic acidosis. The patient was recommended to decrease his nightly Remeron from 45mg to 15mg. He was also scheduled for an outpatient sleep medicine referral due to known history of OSA and noncompliance with CPAP, as this likely has contributed to his current condition. The patient was discharged in stable condition with recommendations to have close PCP follow up and outpatient sleep study as mentioned above."
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cardiac valve disease, Cerebellar infarction, Cerebral artery stenosis
Clinical narrative: Provider d/c note:  "70 YO male with h/o HTN, T2DM, Depression who presented to ED with chief complaint of weakness. The patient reports generalized weakness worse in the left-leg since waking up this morning. He reports that he had difficulty walking which prompted a call to EMS for further evaluation. Of note, patient was evaluated in September 2022 for Bell's Palsy and completed a one week course of Valtrex. He denies chest pain, chest pressure, dyspnea, cough, wheezing, HA, lightheadedness. He reports intermittent paresthesia worse at the b/l feet which is unchanged from baseline. He reports no bowel or bladder incontinence.   In the ED, patient's vitals are significant for BP of 152/76, HR 102, Temp 100.7F, Resp 20, SpO2 89% on RA. He is not on supplemental oxygen at baseline. Initial work-up remarkable for WBC 13.4, Na 133, initial lactate 3.7, normal 4-hour lactate, Procal of 0.32, D-dimer of 610, CRP of 3.8. Coags normal. Initial troponin 23, repeat 22. RVP positive for COVID. Head CT significant for no acute infarct, thrombosis or hemorrhage. Chronic right striatocapsular and R cerebellar small vessel infarcts. CTA head and neck with moderately severe mid-basilar artery and distal left P2 segment stenosis, no hemodynamically significant cervical arterial occlusive change. Chest XR remarkable for subtle nonspecific bibasilar patchy opacities.    Patient was admitted for further stroke work-up and treatment for COVID pneumonia/pneumonitis.   Hospital Course:  Patient's respiratory status improved after hospital Day 1 on oral decadron and IV remdesivir. Patient completed a 5-day course of IV Remdesivir and 5-day course of oral Decadron with plans for additional Decadron therapy for 5-days after discharge. The patient's left-sided weakness resolved. Further stroke work-up with MRI was unremarkable. Echo was remarkable for preseverbed EF with mild grade 1 diastolic dysfunction and mild left atrial enlargement with mild valvular disease but no evidence of active clot or thrombus. With his lipid panel and A1c of 9%, optimization of risk factors was started with starting Lipitor 80mg nightly, Lisinopril 5mg daily, and ASA 81mg daily. The patient's blood sugars were controlled with SSI and Lantus 15U nightly. He was discharged on Soliqua 15U daily and recommendations to stop Metformin as patient was admitted with evidence of lactic acidosis. The patient was recommended to decrease his nightly Remeron from 45mg to 15mg. He was also scheduled for an outpatient sleep medicine referral due to known history of OSA and noncompliance with CPAP, as this likely has contributed to his current condition. The patient was discharged in stable condition with recommendations to have close PCP follow up and outpatient sleep study as mentioned above."
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cerebral infarction, Chest X-ray abnormal, Coagulation test normal, Computerised tomogram head abnormal, Condition aggravated
Clinical narrative: Provider d/c note:  "70 YO male with h/o HTN, T2DM, Depression who presented to ED with chief complaint of weakness. The patient reports generalized weakness worse in the left-leg since waking up this morning. He reports that he had difficulty walking which prompted a call to EMS for further evaluation. Of note, patient was evaluated in September 2022 for Bell's Palsy and completed a one week course of Valtrex. He denies chest pain, chest pressure, dyspnea, cough, wheezing, HA, lightheadedness. He reports intermittent paresthesia worse at the b/l feet which is unchanged from baseline. He reports no bowel or bladder incontinence.   In the ED, patient's vitals are significant for BP of 152/76, HR 102, Temp 100.7F, Resp 20, SpO2 89% on RA. He is not on supplemental oxygen at baseline. Initial work-up remarkable for WBC 13.4, Na 133, initial lactate 3.7, normal 4-hour lactate, Procal of 0.32, D-dimer of 610, CRP of 3.8. Coags normal. Initial troponin 23, repeat 22. RVP positive for COVID. Head CT significant for no acute infarct, thrombosis or hemorrhage. Chronic right striatocapsular and R cerebellar small vessel infarcts. CTA head and neck with moderately severe mid-basilar artery and distal left P2 segment stenosis, no hemodynamically significant cervical arterial occlusive change. Chest XR remarkable for subtle nonspecific bibasilar patchy opacities.    Patient was admitted for further stroke work-up and treatment for COVID pneumonia/pneumonitis.   Hospital Course:  Patient's respiratory status improved after hospital Day 1 on oral decadron and IV remdesivir. Patient completed a 5-day course of IV Remdesivir and 5-day course of oral Decadron with plans for additional Decadron therapy for 5-days after discharge. The patient's left-sided weakness resolved. Further stroke work-up with MRI was unremarkable. Echo was remarkable for preseverbed EF with mild grade 1 diastolic dysfunction and mild left atrial enlargement with mild valvular disease but no evidence of active clot or thrombus. With his lipid panel and A1c of 9%, optimization of risk factors was started with starting Lipitor 80mg nightly, Lisinopril 5mg daily, and ASA 81mg daily. The patient's blood sugars were controlled with SSI and Lantus 15U nightly. He was discharged on Soliqua 15U daily and recommendations to stop Metformin as patient was admitted with evidence of lactic acidosis. The patient was recommended to decrease his nightly Remeron from 45mg to 15mg. He was also scheduled for an outpatient sleep medicine referral due to known history of OSA and noncompliance with CPAP, as this likely has contributed to his current condition. The patient was discharged in stable condition with recommendations to have close PCP follow up and outpatient sleep study as mentioned above."
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diastolic dysfunction, Echocardiogram abnormal, Ejection fraction, Fibrin D dimer, Gait disturbance
Clinical narrative: Provider d/c note:  "70 YO male with h/o HTN, T2DM, Depression who presented to ED with chief complaint of weakness. The patient reports generalized weakness worse in the left-leg since waking up this morning. He reports that he had difficulty walking which prompted a call to EMS for further evaluation. Of note, patient was evaluated in September 2022 for Bell's Palsy and completed a one week course of Valtrex. He denies chest pain, chest pressure, dyspnea, cough, wheezing, HA, lightheadedness. He reports intermittent paresthesia worse at the b/l feet which is unchanged from baseline. He reports no bowel or bladder incontinence.   In the ED, patient's vitals are significant for BP of 152/76, HR 102, Temp 100.7F, Resp 20, SpO2 89% on RA. He is not on supplemental oxygen at baseline. Initial work-up remarkable for WBC 13.4, Na 133, initial lactate 3.7, normal 4-hour lactate, Procal of 0.32, D-dimer of 610, CRP of 3.8. Coags normal. Initial troponin 23, repeat 22. RVP positive for COVID. Head CT significant for no acute infarct, thrombosis or hemorrhage. Chronic right striatocapsular and R cerebellar small vessel infarcts. CTA head and neck with moderately severe mid-basilar artery and distal left P2 segment stenosis, no hemodynamically significant cervical arterial occlusive change. Chest XR remarkable for subtle nonspecific bibasilar patchy opacities.    Patient was admitted for further stroke work-up and treatment for COVID pneumonia/pneumonitis.   Hospital Course:  Patient's respiratory status improved after hospital Day 1 on oral decadron and IV remdesivir. Patient completed a 5-day course of IV Remdesivir and 5-day course of oral Decadron with plans for additional Decadron therapy for 5-days after discharge. The patient's left-sided weakness resolved. Further stroke work-up with MRI was unremarkable. Echo was remarkable for preseverbed EF with mild grade 1 diastolic dysfunction and mild left atrial enlargement with mild valvular disease but no evidence of active clot or thrombus. With his lipid panel and A1c of 9%, optimization of risk factors was started with starting Lipitor 80mg nightly, Lisinopril 5mg daily, and ASA 81mg daily. The patient's blood sugars were controlled with SSI and Lantus 15U nightly. He was discharged on Soliqua 15U daily and recommendations to stop Metformin as patient was admitted with evidence of lactic acidosis. The patient was recommended to decrease his nightly Remeron from 45mg to 15mg. He was also scheduled for an outpatient sleep medicine referral due to known history of OSA and noncompliance with CPAP, as this likely has contributed to his current condition. The patient was discharged in stable condition with recommendations to have close PCP follow up and outpatient sleep study as mentioned above."
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Glycosylated haemoglobin increased, Hemiparesis, Lactic acidosis, Left atrial enlargement, Lipids
Clinical narrative: Provider d/c note:  "70 YO male with h/o HTN, T2DM, Depression who presented to ED with chief complaint of weakness. The patient reports generalized weakness worse in the left-leg since waking up this morning. He reports that he had difficulty walking which prompted a call to EMS for further evaluation. Of note, patient was evaluated in September 2022 for Bell's Palsy and completed a one week course of Valtrex. He denies chest pain, chest pressure, dyspnea, cough, wheezing, HA, lightheadedness. He reports intermittent paresthesia worse at the b/l feet which is unchanged from baseline. He reports no bowel or bladder incontinence.   In the ED, patient's vitals are significant for BP of 152/76, HR 102, Temp 100.7F, Resp 20, SpO2 89% on RA. He is not on supplemental oxygen at baseline. Initial work-up remarkable for WBC 13.4, Na 133, initial lactate 3.7, normal 4-hour lactate, Procal of 0.32, D-dimer of 610, CRP of 3.8. Coags normal. Initial troponin 23, repeat 22. RVP positive for COVID. Head CT significant for no acute infarct, thrombosis or hemorrhage. Chronic right striatocapsular and R cerebellar small vessel infarcts. CTA head and neck with moderately severe mid-basilar artery and distal left P2 segment stenosis, no hemodynamically significant cervical arterial occlusive change. Chest XR remarkable for subtle nonspecific bibasilar patchy opacities.    Patient was admitted for further stroke work-up and treatment for COVID pneumonia/pneumonitis.   Hospital Course:  Patient's respiratory status improved after hospital Day 1 on oral decadron and IV remdesivir. Patient completed a 5-day course of IV Remdesivir and 5-day course of oral Decadron with plans for additional Decadron therapy for 5-days after discharge. The patient's left-sided weakness resolved. Further stroke work-up with MRI was unremarkable. Echo was remarkable for preseverbed EF with mild grade 1 diastolic dysfunction and mild left atrial enlargement with mild valvular disease but no evidence of active clot or thrombus. With his lipid panel and A1c of 9%, optimization of risk factors was started with starting Lipitor 80mg nightly, Lisinopril 5mg daily, and ASA 81mg daily. The patient's blood sugars were controlled with SSI and Lantus 15U nightly. He was discharged on Soliqua 15U daily and recommendations to stop Metformin as patient was admitted with evidence of lactic acidosis. The patient was recommended to decrease his nightly Remeron from 45mg to 15mg. He was also scheduled for an outpatient sleep medicine referral due to known history of OSA and noncompliance with CPAP, as this likely has contributed to his current condition. The patient was discharged in stable condition with recommendations to have close PCP follow up and outpatient sleep study as mentioned above."
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lung opacity, Magnetic resonance imaging normal, Muscular weakness, Paraesthesia, Procalcitonin
Clinical narrative: Provider d/c note:  "70 YO male with h/o HTN, T2DM, Depression who presented to ED with chief complaint of weakness. The patient reports generalized weakness worse in the left-leg since waking up this morning. He reports that he had difficulty walking which prompted a call to EMS for further evaluation. Of note, patient was evaluated in September 2022 for Bell's Palsy and completed a one week course of Valtrex. He denies chest pain, chest pressure, dyspnea, cough, wheezing, HA, lightheadedness. He reports intermittent paresthesia worse at the b/l feet which is unchanged from baseline. He reports no bowel or bladder incontinence.   In the ED, patient's vitals are significant for BP of 152/76, HR 102, Temp 100.7F, Resp 20, SpO2 89% on RA. He is not on supplemental oxygen at baseline. Initial work-up remarkable for WBC 13.4, Na 133, initial lactate 3.7, normal 4-hour lactate, Procal of 0.32, D-dimer of 610, CRP of 3.8. Coags normal. Initial troponin 23, repeat 22. RVP positive for COVID. Head CT significant for no acute infarct, thrombosis or hemorrhage. Chronic right striatocapsular and R cerebellar small vessel infarcts. CTA head and neck with moderately severe mid-basilar artery and distal left P2 segment stenosis, no hemodynamically significant cervical arterial occlusive change. Chest XR remarkable for subtle nonspecific bibasilar patchy opacities.    Patient was admitted for further stroke work-up and treatment for COVID pneumonia/pneumonitis.   Hospital Course:  Patient's respiratory status improved after hospital Day 1 on oral decadron and IV remdesivir. Patient completed a 5-day course of IV Remdesivir and 5-day course of oral Decadron with plans for additional Decadron therapy for 5-days after discharge. The patient's left-sided weakness resolved. Further stroke work-up with MRI was unremarkable. Echo was remarkable for preseverbed EF with mild grade 1 diastolic dysfunction and mild left atrial enlargement with mild valvular disease but no evidence of active clot or thrombus. With his lipid panel and A1c of 9%, optimization of risk factors was started with starting Lipitor 80mg nightly, Lisinopril 5mg daily, and ASA 81mg daily. The patient's blood sugars were controlled with SSI and Lantus 15U nightly. He was discharged on Soliqua 15U daily and recommendations to stop Metformin as patient was admitted with evidence of lactic acidosis. The patient was recommended to decrease his nightly Remeron from 45mg to 15mg. He was also scheduled for an outpatient sleep medicine referral due to known history of OSA and noncompliance with CPAP, as this likely has contributed to his current condition. The patient was discharged in stable condition with recommendations to have close PCP follow up and outpatient sleep study as mentioned above."
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory viral panel, SARS-CoV-2 test positive, Troponin increased, White blood cell count increased
Clinical narrative: Provider d/c note:  "70 YO male with h/o HTN, T2DM, Depression who presented to ED with chief complaint of weakness. The patient reports generalized weakness worse in the left-leg since waking up this morning. He reports that he had difficulty walking which prompted a call to EMS for further evaluation. Of note, patient was evaluated in September 2022 for Bell's Palsy and completed a one week course of Valtrex. He denies chest pain, chest pressure, dyspnea, cough, wheezing, HA, lightheadedness. He reports intermittent paresthesia worse at the b/l feet which is unchanged from baseline. He reports no bowel or bladder incontinence.   In the ED, patient's vitals are significant for BP of 152/76, HR 102, Temp 100.7F, Resp 20, SpO2 89% on RA. He is not on supplemental oxygen at baseline. Initial work-up remarkable for WBC 13.4, Na 133, initial lactate 3.7, normal 4-hour lactate, Procal of 0.32, D-dimer of 610, CRP of 3.8. Coags normal. Initial troponin 23, repeat 22. RVP positive for COVID. Head CT significant for no acute infarct, thrombosis or hemorrhage. Chronic right striatocapsular and R cerebellar small vessel infarcts. CTA head and neck with moderately severe mid-basilar artery and distal left P2 segment stenosis, no hemodynamically significant cervical arterial occlusive change. Chest XR remarkable for subtle nonspecific bibasilar patchy opacities.    Patient was admitted for further stroke work-up and treatment for COVID pneumonia/pneumonitis.   Hospital Course:  Patient's respiratory status improved after hospital Day 1 on oral decadron and IV remdesivir. Patient completed a 5-day course of IV Remdesivir and 5-day course of oral Decadron with plans for additional Decadron therapy for 5-days after discharge. The patient's left-sided weakness resolved. Further stroke work-up with MRI was unremarkable. Echo was remarkable for preseverbed EF with mild grade 1 diastolic dysfunction and mild left atrial enlargement with mild valvular disease but no evidence of active clot or thrombus. With his lipid panel and A1c of 9%, optimization of risk factors was started with starting Lipitor 80mg nightly, Lisinopril 5mg daily, and ASA 81mg daily. The patient's blood sugars were controlled with SSI and Lantus 15U nightly. He was discharged on Soliqua 15U daily and recommendations to stop Metformin as patient was admitted with evidence of lactic acidosis. The patient was recommended to decrease his nightly Remeron from 45mg to 15mg. He was also scheduled for an outpatient sleep medicine referral due to known history of OSA and noncompliance with CPAP, as this likely has contributed to his current condition. The patient was discharged in stable condition with recommendations to have close PCP follow up and outpatient sleep study as mentioned above."
Age: 1.42
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vaccine was stored for a total of 11 days past its beyond use date in the refrigerator.  Patient did not experience any adverse events.
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Headache
Clinical narrative: Headache- can be mild to severe but hasn't resolved since receiving the vaccine.  Patient has taken Tylenol but that does not seem to help.
Age: 27.0
Sex: F
Vaccine: FLU4
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: RT shoulder pain and reduced ROM
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Temperature Excursion. Vaccine was stored refrigerated (2-8 degrees Celsius) for greater than 10 weeks.  Vaccine was stored for a total of 8 days past its beyond use date in the refrigerator.  Patient did not experience any adverse events.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Death
Clinical narrative: Found dead at home on 11/01/2022.
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: covid positive pt, vaccinated, hospitalized
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 09/06/22 presents to ED for "fatigue". PMHx of " AML (diagnosed in 2017), hepatitis C, HLD, HTN, RA and nephrolithiasis"
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Temperature Excursion. Vaccine was stored refrigerated (2-8 degrees Celsius) for greater than 10 weeks.  Vaccine was stored for a total of 8 days past its beyond use date in the refrigerator.  Patient did not experience any adverse events.
Age: 57.0
Sex: F
Vaccine: FLU4
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: Patient experienced severe pain in her arm and could not left her arm up past midway.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Erythema, Fatigue, Skin discolouration, Urticaria
Clinical narrative: Vomiting - extreme exhaustion - red welt on arm which traveled down to my elbow.  the area that had the weld is now discolored and looks like bruising but it's been over 2 weeks
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Vomiting - extreme exhaustion - red welt on arm which traveled down to my elbow.  the area that had the weld is now discolored and looks like bruising but it's been over 2 weeks
Age: 1.25
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Temperature Excursion. Vaccine was stored refrigerated (2-8 degrees Celsius) for greater than 10 weeks.  Vaccine was stored for a total of 8 days past its beyond use date in the refrigerator.  Patient did not experience any adverse events.
Age: 30.0
Sex: F
Vaccine: FLUC4
Symptoms: Emotional disorder, Fatigue, Headache, Nausea, Throat irritation
Clinical narrative: first day: hives, throat irritation, headache second day: headache continued, nausea, extreme fatigue third day: fatigue, nausea, emotional--missed school fourth day: fatigue wore off, less nausea, still emotional fifth and sixth days: emotional state improved
Age: 30.0
Sex: F
Vaccine: FLUC4
Symptoms: Urticaria
Clinical narrative: first day: hives, throat irritation, headache second day: headache continued, nausea, extreme fatigue third day: fatigue, nausea, emotional--missed school fourth day: fatigue wore off, less nausea, still emotional fifth and sixth days: emotional state improved
Age: 41.0
Sex: F
Vaccine: UNK, UNK
Symptoms: Biopsy skin abnormal, Blister, Burning sensation, Condition aggravated, Impaired quality of life
Clinical narrative: 1st vaccine 10/15/21 few days after first vaccine palms developed tiny almost blisters mainly right hand burning intense itching sensation i notified occupational health and was still advised i had to receive second vaccine in order to be compliant 2nd vaccine 11/5/21 my hands continued with reaction to the point my skin started peeling off the intensity of pain became so unbearable i had a heartbeat in palm of hand unable to sleep called in to work at 12/20/21 to seek help went to dermatologist 12/20/21 he prescribed oral,topical steroids and steriod injection and was unfamiliar with covid vaccine side effects and thought perhaps it would subside with steroids or possibly psoriasis he wasnt sure of auto immune system response  with covid vaccination. at the same time my right knee swelled however no injury .fast forward another dermatologist stelera did not help or steroids currently skyrizi has not helped today my palm has never healed severe painful cracks it limits my daily functions had biopsy and is palmar psoriasis which is life long .i was referred to rheumatologist by orthopedic my large right knee effusion seen on MRI and x-ray  80ml of fluid was drained/collected rheumatologist stated i had psoriatic arthritis which is life long. I expressed my concerns for exemption prior to vaccine since I had two autoimmune diseases and Dr. our hospital physician deemed that I be vaccinated and even the second vaccine after expressing reaction concerns. Since this Vaccine my quality of life has dramatically changed pain, physical, emotional, not to mention this will never go away.
Age: 41.0
Sex: F
Vaccine: UNK, UNK
Symptoms: Impaired work ability, Insomnia, Joint effusion, Joint fluid drainage, Joint swelling
Clinical narrative: 1st vaccine 10/15/21 few days after first vaccine palms developed tiny almost blisters mainly right hand burning intense itching sensation i notified occupational health and was still advised i had to receive second vaccine in order to be compliant 2nd vaccine 11/5/21 my hands continued with reaction to the point my skin started peeling off the intensity of pain became so unbearable i had a heartbeat in palm of hand unable to sleep called in to work at 12/20/21 to seek help went to dermatologist 12/20/21 he prescribed oral,topical steroids and steriod injection and was unfamiliar with covid vaccine side effects and thought perhaps it would subside with steroids or possibly psoriasis he wasnt sure of auto immune system response  with covid vaccination. at the same time my right knee swelled however no injury .fast forward another dermatologist stelera did not help or steroids currently skyrizi has not helped today my palm has never healed severe painful cracks it limits my daily functions had biopsy and is palmar psoriasis which is life long .i was referred to rheumatologist by orthopedic my large right knee effusion seen on MRI and x-ray  80ml of fluid was drained/collected rheumatologist stated i had psoriatic arthritis which is life long. I expressed my concerns for exemption prior to vaccine since I had two autoimmune diseases and Dr. our hospital physician deemed that I be vaccinated and even the second vaccine after expressing reaction concerns. Since this Vaccine my quality of life has dramatically changed pain, physical, emotional, not to mention this will never go away.